Antimicrobial Peptides Targeting Streptococcus mutans: Current Research on Design, Screening and Efficacy.


Journal

Current microbiology
ISSN: 1432-0991
Titre abrégé: Curr Microbiol
Pays: United States
ID NLM: 7808448

Informations de publication

Date de publication:
25 Nov 2023
Historique:
received: 15 05 2023
accepted: 26 10 2023
medline: 27 11 2023
pubmed: 26 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Antimicrobial peptides (AMPs) are small-molecule peptides that play a vital role in the nonspecific immune defense system of organisms. They mainly kill microorganisms by physically destroying the cell membrane and causing the leakage of contents. AMPs have attracted much attention as potential alternatives to antibiotics due to their low susceptibility to resistance. Streptococcus mutans (S. mutans) is one of the main causative agents of human dental caries. The design, screening, and efficacy evaluation of AMPs targeting S. mutans offer new possibilities for the prevention and treatment of oral diseases, especially dental caries, in the future. This article reviews AMPs from different sources that have inhibitory effects on S. mutans, discusses the mechanism of action of AMPs against S. mutans biofilms, and focuses on the research progress of screening methods, design modification, and biological activity evaluation of AMPs. We hope to provide insights and reference value for the development of new biologics.

Identifiants

pubmed: 38007405
doi: 10.1007/s00284-023-03540-5
pii: 10.1007/s00284-023-03540-5
doi:

Substances chimiques

Antimicrobial Peptides 0
Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Subventions

Organisme : Shanghai Natural Science Foundation of China Grant
ID : 19ZR1461600

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Lazzaro BP, Zasloff M, Rolff J (2020) Antimicrobial peptides: application informed by evolution. Science. https://doi.org/10.1126/science.aau5480
doi: 10.1126/science.aau5480 pubmed: 32355003 pmcid: 8097767
Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ (2020) Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov 19:311–332. https://doi.org/10.1038/s41573-019-0058-8
doi: 10.1038/s41573-019-0058-8 pubmed: 32107480
da Silva BR, Conrado AJS, Pereira AL, Evaristo FFV, Arruda FVS, Vasconcelos MA, Lorenzón EN, Cilli EM, Teixeira EH (2017) Antibacterial activity of a novel antimicrobial peptide [W7]KR12-KAEK derived from KR-12 against Streptococcus mutans planktonic cells and biofilms. Biofouling 33:835–846. https://doi.org/10.1080/08927014.2017.1374378
doi: 10.1080/08927014.2017.1374378 pubmed: 28967271
Jiang W, Wang Y, Luo J, Chen X, Zeng Y, Li X, Feng Z, Zhang L (2020) Antimicrobial peptide GH12 prevents dental caries by regulating dental plaque microbiota. Appl Environ Microbiol. https://doi.org/10.1128/aem.00527-20
doi: 10.1128/aem.00527-20 pubmed: 33355103 pmcid: 7755249
Capasso C, Supuran CT (2016) An overview of the carbonic anhydrases from two pathogens of the oral cavity: Streptococcus mutans and Porphyromonas gingivalis. Curr Top Med Chem 16:2359–2368. https://doi.org/10.2174/1568026616666160413135522
doi: 10.2174/1568026616666160413135522 pubmed: 27072694
Ribeiro TR, Dria KJ, de Carvalho CBM, Monteiro AJ, Fonteles MC, de Moraes CK, Fonteles CSR (2013) Salivary peptide profile and its association with early childhood caries. Int J Pediatr Dent 23:225–234. https://doi.org/10.1111/j.1365-263X.2012.01258.x
doi: 10.1111/j.1365-263X.2012.01258.x
Liu Y, Kamesh AC, Xiao Y, Sun V, Hayes M, Daniell H, Koo H (2016) Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells. Biomaterials 105:156–166. https://doi.org/10.1016/j.biomaterials.2016.07.042
doi: 10.1016/j.biomaterials.2016.07.042 pubmed: 27521618 pmcid: 5310780
Jug M, Kosalec I, Maestrelli F, Mura P (2012) Development of low methoxy amidated pectin-based mucoadhesive patches for buccal delivery of triclosan: effect of cyclodextrin complexation. Carbohyd Polym 90:1794–1803. https://doi.org/10.1016/j.carbpol.2012.07.074
doi: 10.1016/j.carbpol.2012.07.074
Su M, Yao S, Gu L, Huang Z, Mai S (2018) Antibacterial effect and bond strength of a modified dental adhesive containing the peptide nisin. Peptides 99:189–194. https://doi.org/10.1016/j.peptides.2017.10.003
doi: 10.1016/j.peptides.2017.10.003 pubmed: 29024714
Consortium HMP (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. https://doi.org/10.1038/nature11234
doi: 10.1038/nature11234
Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR 3rd, Heydorn A, Koo H (2012) The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm. PLoS Pathog 8:e1002623. https://doi.org/10.1371/journal.ppat.1002623
doi: 10.1371/journal.ppat.1002623 pubmed: 22496649 pmcid: 3320608
Singh N, Das PP (2022) Microbial biofilms. Core Microbiome 54:249–267
doi: 10.1002/9781119830795.ch15
Matsumoto-Nakano M (2018) Role of Streptococcus mutans surface proteins for biofilm formation. Jpn Dental Sci Rev 54:22–29. https://doi.org/10.1016/j.jdsr.2017.08.002
doi: 10.1016/j.jdsr.2017.08.002
Álvarez S, Leiva-Sabadini C, Schuh C, Aguayo S (2022) Bacterial adhesion to collagens: implications for biofilm formation and disease progression in the oral cavity. Crit Rev Microbiol 48:83–95. https://doi.org/10.1080/1040841x.2021.1944054
doi: 10.1080/1040841x.2021.1944054 pubmed: 34270375
Bowen WH, Koo H (2011) Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms. Caries Res 45:69–86. https://doi.org/10.1159/000324598
doi: 10.1159/000324598 pubmed: 21346355 pmcid: 3068567
Lynch DJ, Fountain TL, Mazurkiewicz JE, Banas JA (2007) Glucan-binding proteins are essential for shaping Streptococcus mutans biofilm architecture. FEMS Microbiol Lett 268:158–165. https://doi.org/10.1111/j.1574-6968.2006.00576.x
doi: 10.1111/j.1574-6968.2006.00576.x pubmed: 17214736
Yadav P, Verma S, Bauer R, Kumari M, Dua M, Johri AK, Yadav V, Spellerberg B (2020) Deciphering streptococcal biofilms. Microorganisms. https://doi.org/10.3390/microorganisms8111835
doi: 10.3390/microorganisms8111835 pubmed: 33374217 pmcid: 7824458
Matsumoto-Nakano M, Tsuji M, Amano A, Ooshima T (2008) Molecular interactions of alanine-rich and proline-rich regions of cell surface protein antigen c in Streptococcus mutans. Oral Microbiol Immunol 23:265–270. https://doi.org/10.1111/j.1399-302X.2007.00421.x
doi: 10.1111/j.1399-302X.2007.00421.x pubmed: 18582324
Aviles-Reyes A, Miller JH, Simpson-Haidaris PJ, Lemos JA, Abranches J (2014) Cnm is a major virulence factor of invasive Streptococcus mutans and part of a conserved three-gene locus. Mol Oral Microbiol 29:11–23. https://doi.org/10.1111/mom.12041
doi: 10.1111/mom.12041 pubmed: 24103776
Kaur G, Balamurugan P, Princy SA (2017) Inhibition of the quorum sensing system (ComDE pathway) by aromatic 1,3-di-m-tolylurea (DMTU): cariostatic effect with fluoride in wistar rats. Front Cell Infect Microbiol 7:313. https://doi.org/10.3389/fcimb.2017.00313
doi: 10.3389/fcimb.2017.00313 pubmed: 28748175 pmcid: 5506180
Di Salle A, Viscusi G, Di Cristo F, Valentino A, Gorrasi G, Lamberti E, Vittoria V, Calarco A, Peluso G (2021) Antimicrobial and antibiofilm activity of curcumin-loaded electrospun nanofibers for the prevention of the biofilm-associated infections. Molecules. https://doi.org/10.3390/molecules26164866
doi: 10.3390/molecules26164866 pubmed: 34443457 pmcid: 8400440
Liu S, Sun Y, Liu Y, Hu F, Xu L, Zheng Q, Wang Q, Zeng G, Zhang K (2022) Genomic and phenotypic characterization of Streptococcus mutans isolates suggests key gene clusters in regulating its interaction with Streptococcus gordonii. Front Microbiol 13:945108. https://doi.org/10.3389/fmicb.2022.945108
doi: 10.3389/fmicb.2022.945108 pubmed: 36033899 pmcid: 9416482
Schaefers MM (2020) Regulation of virulence by two-component systems in pathogenic Burkholderia. Infect Immun. https://doi.org/10.1128/iai.00927-19
doi: 10.1128/iai.00927-19 pubmed: 32284365 pmcid: 7309619
Li YuW, Ming Chen J, Sun Y, Geng XP (2017) Targeting two-component signal-transduction systems of bacteria for go od potential drug design. J Intensive Crit Care 2:210. https://doi.org/10.21767/2471-8505.100012
doi: 10.21767/2471-8505.100012
Wang W-L, Liu J, Huo Y-B, Ling J-Q (2013) Bacteriocin immunity proteins play a role in quorum-sensing system regulated antimicrobial sensitivity of Streptococcus mutans UA159. Arch Oral Biol 58:384–390. https://doi.org/10.1016/j.archoralbio.2012.09.001
doi: 10.1016/j.archoralbio.2012.09.001 pubmed: 23107045
Matsumoto-Nakano M, Kuramitsu HK (2006) Role of bacteriocin immunity proteins in the antimicrobial sensitivity of Streptococcus mutans. J Bacteriol 188:8095–8102. https://doi.org/10.1128/JB.00908-06
doi: 10.1128/JB.00908-06 pubmed: 16997961 pmcid: 1698205
Wei Y, Sturges CI, Palmer KL (2023) Human serum supplementation promotes streptococcus mitis growth and induces specific transcriptomic responses. Microbiol Spectr 11:e0512922. https://doi.org/10.1128/spectrum.05129-22
doi: 10.1128/spectrum.05129-22 pubmed: 37014220
He L-Y, Le Y-J, Guo Z, Li S, Yang X-Y (2021) The role and regulatory network of the CiaRH two-component system in streptococcal species. Front Microbiol. https://doi.org/10.3389/fmicb.2021.693858
doi: 10.3389/fmicb.2021.693858 pubmed: 35310394 pmcid: 8717896
Lévesque CM, Mair RW, Perry JA, Lau PC, Li YH, Cvitkovitch DG (2007) Systemic inactivation and phenotypic characterization of two-component systems in expression of Streptococcus mutans virulence properties. Lett Appl Microbiol 45:398–404. https://doi.org/10.1111/j.1472-765X.2007.02203.x
doi: 10.1111/j.1472-765X.2007.02203.x pubmed: 17897382 pmcid: 2062497
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395. https://doi.org/10.1038/415389a
doi: 10.1038/415389a pubmed: 11807545
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250. https://doi.org/10.1038/nrmicro1098
doi: 10.1038/nrmicro1098 pubmed: 15703760
Niu JY, Yin IX, Wu WKK, Li Q-L, Mei ML, Chu CH (2021) Antimicrobial peptides for the prevention and treatment of dental caries: a concise review. Arch Oral Biol 122:105022. https://doi.org/10.1016/j.archoralbio.2020.105022
doi: 10.1016/j.archoralbio.2020.105022 pubmed: 33418434
Luong AD, Buzid A, Luong JHT (2022) Important roles and potential uses of natural and synthetic antimicrobial peptides (AMPs) in oral diseases: cavity, periodontal disease, and thrush. J Funct Biomater 13:175
doi: 10.3390/jfb13040175 pubmed: 36278644 pmcid: 9589978
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720. https://doi.org/10.1038/nri1180
doi: 10.1038/nri1180 pubmed: 12949495
Zhai YJ, Feng Y, Ma X, Ma F (2023) Defensins: defenders of human reproductive health. Hum Reprod Update 29:126–154. https://doi.org/10.1093/humupd/dmac032
doi: 10.1093/humupd/dmac032 pubmed: 36130055
Wuersching SN, Huth KC, Hickel R, Kollmuss M (2021) Inhibitory effect of LL-37 and human lactoferricin on growth and biofilm formation of anaerobes associated with oral diseases. Anaerobe 67:102301. https://doi.org/10.1016/j.anaerobe.2020.102301
doi: 10.1016/j.anaerobe.2020.102301 pubmed: 33249255
Zeth K, Sancho-Vaello E (2021) Structural plasticity of LL-37 indicates elaborate functional adaptation mechanisms to bacterial target structures. Int J Mol Sci. https://doi.org/10.3390/ijms22105200
doi: 10.3390/ijms22105200 pubmed: 34068993 pmcid: 8156758
Wuersching SN, Huth KC, Hickel R, Kollmuss M (2021) Targeting antibiotic tolerance in anaerobic biofilms associated with oral diseases: Human antimicrobial peptides LL-37 and lactoferricin enhance the antibiotic efficacy of amoxicillin, clindamycin and metronidazole. Anaerobe 71:102439. https://doi.org/10.1016/j.anaerobe.2021.102439
doi: 10.1016/j.anaerobe.2021.102439 pubmed: 34454095
Zolin GVS, Fonseca FHD, Zambom CR, Garrido SS (2021) Histatin 5 metallopeptides and their potential against Candida albicans pathogenicity and drug resistance. Biomolecules. https://doi.org/10.3390/biom11081209
doi: 10.3390/biom11081209 pubmed: 34439875 pmcid: 8391865
Mason AJ, Bertani P, Moulay G, Marquette A, Perrone B, Drake AF, Kichler A, Bechinger B (2007) Membrane interaction of chrysophsin-1, a histidine-rich antimicrobial peptide from red sea bream. Biochemistry 46:15175–15187. https://doi.org/10.1021/bi701344m
doi: 10.1021/bi701344m pubmed: 18052076
Aa-S K, Hozzein WN (2022) Antibacterial activities of two potential peptides extracted from Polistes wattii Cameron, 1900 (Vespidae: Polistinae) wasp venom collected at Eastern Province. Saudi Arabia PLoS One 17:e0264035. https://doi.org/10.1371/journal.pone.0264035
doi: 10.1371/journal.pone.0264035
Cai S, Meng K, Liu P, Cao X, Wang G (2021) Suppressive effects of gecko cathelicidin on biofilm formation and cariogenic virulence factors of Streptococcus mutans. Arch Oral Biol 129:105205. https://doi.org/10.1016/j.archoralbio.2021.105205
doi: 10.1016/j.archoralbio.2021.105205 pubmed: 34237581
Kokilakanit P, Koontongkaew S, Roytrakul S, Utispan K (2020) A novel non-cytotoxic synthetic peptide, Pug-1, exhibited an antibiofilm effect on Streptococcus mutans adhesion. Lett Appl Microbiol 70:151–158. https://doi.org/10.1111/lam.13265
doi: 10.1111/lam.13265 pubmed: 31837275
Bédard F, Biron E (2018) Recent progress in the chemical synthesis of class II and S-glycosylated bacteriocins. Front Microbiol 9:1048. https://doi.org/10.3389/fmicb.2018.01048
doi: 10.3389/fmicb.2018.01048 pubmed: 29875754 pmcid: 5974097
Lopes SR, Matuda AGN, Campos RP, Mafetano A, Barnabe AHM, Chagas GS, Barcellos DC, Niu LN, Tay FR, Pucci CR (2022) Development of an antibacterial dentin adhesive. Polymers. https://doi.org/10.3390/polym14122502
doi: 10.3390/polym14122502 pubmed: 36559899 pmcid: 9785248
Kawada-Matsuo M, Komatsuzawa H (2017) Role of Streptococcus mutans two-component systems in antimicrobial peptide resistance in the oral cavity. Jpn Dental Sci Rev 53:86–94. https://doi.org/10.1016/j.jdsr.2016.12.002
doi: 10.1016/j.jdsr.2016.12.002
Yamakami K, Tsumori H, Sakurai Y, Shimizu Y, Nagatoshi K, Sonomoto K (2013) Sustainable inhibition efficacy of liposome-encapsulated nisin on insoluble glucan-biofilm synthesis by Streptococcus mutans. Pharm Biol 51:267–270. https://doi.org/10.3109/13880209.2012.717227
doi: 10.3109/13880209.2012.717227 pubmed: 23116173
Tanhaieian A, Pourgonabadi S, Akbari M, Mohammadipour HS (2020) The effective and safe method for preventing and treating bacteria-induced dental diseases by herbal plants and a recombinant peptide. J Clin Exp Dent 12:e523–e532. https://doi.org/10.4317/jced.55717
doi: 10.4317/jced.55717 pubmed: 32665810 pmcid: 7335610
Tossi A, Sandri L, Giangaspero A (2000) Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4–30. https://doi.org/10.1002/1097-0282(2000)55:1%3c4::Aid-bip30%3e3.0.Co;2-m
doi: 10.1002/1097-0282(2000)55:1<4::Aid-bip30>3.0.Co;2-m pubmed: 10931439
Wiradharma N, Khoe U, Hauser CAE, Seow SV, Zhang S, Yang Y-Y (2011) Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents. Biomaterials 32:2204–2212. https://doi.org/10.1016/j.biomaterials.2010.11.054
doi: 10.1016/j.biomaterials.2010.11.054 pubmed: 21168911
Gan BH, Gaynord J, Rowe SM, Deingruber T, Spring DR (2021) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 50:7820–7880. https://doi.org/10.1039/d0cs00729c
doi: 10.1039/d0cs00729c pubmed: 34042120 pmcid: 8689412
Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ (2016) From a pro-apoptotic peptide to a lytic peptide: one single residue mutation. Biochim Biophys Acta 1858:1914–1925. https://doi.org/10.1016/j.bbamem.2016.05.012
doi: 10.1016/j.bbamem.2016.05.012 pubmed: 27207743
Chen L, Jia L, Zhang Q, Zhou X, Liu Z, Li B, Zhu Z, Wang F, Yu C, Zhang Q, Chen F, Luo S-Z (2017) A novel antimicrobial peptide against dental-caries-associated bacteria. Anaerobe 47:165–172. https://doi.org/10.1016/j.anaerobe.2017.05.016
doi: 10.1016/j.anaerobe.2017.05.016 pubmed: 28571698
Ito T, Ichinosawa T, Shimizu T (2017) Streptococcal adhesin SspA/B analogue peptide inhibits adherence and impacts biofilm formation of Streptococcus mutans. PLoS ONE 12:e0175483. https://doi.org/10.1371/journal.pone.0175483
doi: 10.1371/journal.pone.0175483 pubmed: 28394940 pmcid: 5386287
Chen Z, Yang G, Lu S, Chen D, Fan S, Xu J, Wu B, He J (2019) Design and antimicrobial activities of LL-37 derivatives inhibiting the formation of Streptococcus mutans biofilm. Chem Biol Drug Des 93:1175–1185. https://doi.org/10.1111/cbdd.13419
doi: 10.1111/cbdd.13419 pubmed: 30635992
Zhang P, Wu S, Li J, Bu X, Dong X, Chen N, Li F, Zhu J, Sang L, Zeng Y, Liang S, Yu Z, Liu Z (2022) Dual-sensitive antibacterial peptide nanoparticles prevent dental caries. Theranostics 12:4818–4833. https://doi.org/10.7150/thno.73181
doi: 10.7150/thno.73181 pubmed: 35832082 pmcid: 9254247
Liang D, Li H, Xu X, Liang J, Dai X, Zhao W (2019) Design, screening and antimicrobial activity of novel peptides against Streptococcus mutans. Nan Fang Yi Ke Da Xue Xue Bao 39:823–829. https://doi.org/10.12122/j.issn.1673-4254.2019.07.12
doi: 10.12122/j.issn.1673-4254.2019.07.12 pubmed: 31340916
Liang J, Liang D, Liang Y, He J, Zuo S, Zhao W (2021) Effects of a derivative of reutericin 6 and gassericin A on the biofilm of Streptococcus mutans in vitro and caries prevention in vivo. Odontology 109:53–66. https://doi.org/10.1007/s10266-020-00529-5
doi: 10.1007/s10266-020-00529-5 pubmed: 32474673
Gautier R, Douguet D, Antonny B, Drin G (2008) HELIQUEST: a web server to screen sequences with specific alpha-helical properties. Bioinformatics 24:2101–2102. https://doi.org/10.1093/bioinformatics/btn392
doi: 10.1093/bioinformatics/btn392 pubmed: 18662927
He J, Liang D, Liang Y, Zuo S, Zhao W (2021) Design, screening and antibacterial activity evaluation of the novel antibacterial peptide KR-1. Nan Fang Yi Ke Da Xue Xue Bao 41:923–930. https://doi.org/10.12122/j.issn.1673-4254.2021.06.16
doi: 10.12122/j.issn.1673-4254.2021.06.16 pubmed: 34238746
da Silva BR, de Freitas VAA, Carneiro VA, Arruda FVS, Lorenzón EN, de Aguiar ASW, Cilli EM, Cavada BS, Teixeira EH (2013) Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci. Peptides 42:78–83. https://doi.org/10.1016/j.peptides.2012.12.001
doi: 10.1016/j.peptides.2012.12.001 pubmed: 23340019
Shang D, Liang H, Wei S, Yan X, Yang Q, Sun Y (2014) Effects of antimicrobial peptide L-K6, a temporin-1CEb analog on oral pathogen growth, Streptococcus mutans biofilm formation, and anti-inflammatory activity. Appl Microbiol Biotechnol 98:8685–8695. https://doi.org/10.1007/s00253-014-5927-9
doi: 10.1007/s00253-014-5927-9 pubmed: 25056289
Zhou L, Wong HM, Zhang YY, Li QL (2020) Constructing an Antibiofouling and Mineralizing Bioactive Tooth Surface to Protect against Decay and Promote Self-Healing. ACS Appl Mater Interfaces 12:3021–3031. https://doi.org/10.1021/acsami.9b19745
doi: 10.1021/acsami.9b19745 pubmed: 31877018
Zhou L, Li QL, Wong HM (2021) A novel strategy for caries management: constructing an antibiofouling and mineralizing dual-bioactive tooth surface. ACS Appl Mater Interfaces 13:31140–31152. https://doi.org/10.1021/acsami.1c06989
doi: 10.1021/acsami.1c06989 pubmed: 34156831
Zhang L-y, Fang Z-h, Q-l Li, Cao CY (2019) A tooth-binding antimicrobial peptide to prevent the formation of dental biofilm. J Mater Sci 30:45. https://doi.org/10.1007/s10856-019-6246-6
doi: 10.1007/s10856-019-6246-6
Niu JY, Yin IX, Wu WKK, Li Q-L, Mei ML, Chu CH (2022) Efficacy of the dual-action GA-KR12 peptide for remineralising initial enamel caries: an in vitro study. Clin Oral Invest 26:2441–2451. https://doi.org/10.1007/s00784-021-04210-1
doi: 10.1007/s00784-021-04210-1
Min KR, Galvis A, Williams B, Rayala R, Cudic P, Ajdic D (2017) Antibacterial and antibiofilm activities of a novel synthetic cyclic lipopeptide against cariogenic Streptococcus mutans UA159. Antimicrob Agents Chemother. https://doi.org/10.1128/aac.00776-17
doi: 10.1128/aac.00776-17 pubmed: 28674057 pmcid: 5571348
Xiang S-W, Shao J, He J, Wu X-Y, Xu X-H, Zhao W-H (2019) A membrane-targeted peptide inhibiting PtxA of phosphotransferase system blocks Streptococcus mutans. Caries Res 53:176–193
doi: 10.1159/000489607 pubmed: 30107375
Huo L, Huang X, Ling J, Liu H, Liu J (2018) Selective activities of STAMPs against Streptococcus mutans. Exp Ther Med 15:1886–1893. https://doi.org/10.3892/etm.2017.5631
doi: 10.3892/etm.2017.5631 pubmed: 29434779
Tian XLCC, Cyr K, Dong G, Salim H et al (2017) Targeted killing of Streptococcus mutans in biofilms by a pheromone guided antimicrobial peptide HP30. J Antibio Res 1(2):2018
Almaaytah A, Tarazi S, Al-Fandi M, Abuilhaija A, Al-shar’i N, Al-Balas Q, Abu-Awad A (2015) the design and functional characterization of the antimicrobial and antibiofilm activities of BMAP27-melittin, a rationally designed hybrid peptide. Int J Pept Res Ther 21:165–177. https://doi.org/10.1007/s10989-014-9444-6
doi: 10.1007/s10989-014-9444-6
Wang X, Wang Y, Wang K, Ren Q, Li H, Zheng S, Niu Y, Zhou X, Li W, Zhang L (2019) Bifunctional anticaries peptides with antibacterial and remineralizing effects. Oral Dis 25:488–496. https://doi.org/10.1111/odi.12990
doi: 10.1111/odi.12990 pubmed: 30291730
Mai J, Tian X-L, Gallant Jeffrey W, Merkley N, Biswas Z, Syvitski R, Douglas Susan E, Ling J, Li Y-H (2011) A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans. Antimicrob Agents Chemother 55:5205–5213. https://doi.org/10.1128/AAC.05175-11
doi: 10.1128/AAC.05175-11 pubmed: 21844316 pmcid: 3194993
He J, Yarbrough DK, Kreth J, Anderson MH, Shi W, Eckert R (2010) Systematic approach to optimizing specifically targeted antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother 54:2143–2151. https://doi.org/10.1128/aac.01391-09
doi: 10.1128/aac.01391-09 pubmed: 20211885 pmcid: 2863653
Baker JL, He X, Shi W (2019) Precision reengineering of the oral microbiome for caries management. Adv Dent Res 30:34–39. https://doi.org/10.1177/0022034519877386
doi: 10.1177/0022034519877386 pubmed: 31633390 pmcid: 6806128
Kaplan CW, Sim JH, Shah KR, Kolesnikova-Kaplan A, Shi W, Eckert R (2011) Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide. Antimicrob Agents Chemother 55:3446–3452. https://doi.org/10.1128/aac.00342-11
doi: 10.1128/aac.00342-11 pubmed: 21518845 pmcid: 3122425
Eckert R, Sullivan R, Shi W (2012) Targeted antimicrobial treatment to Re-establish a healthy microbial flora for long-term protection. Adv Dent Res 24:94–97. https://doi.org/10.1177/0022034512453725
doi: 10.1177/0022034512453725 pubmed: 22899688 pmcid: 3420366
Guo L, McLean JS, Yang Y, Eckert R, Kaplan CW, Kyme P, Sheikh O, Varnum B, Lux R, Shi W, He X (2015) Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology. Proc Natl Acad Sci USA 112:7569–7574. https://doi.org/10.1073/pnas.1506207112
doi: 10.1073/pnas.1506207112 pubmed: 26034276 pmcid: 4475959
Guo L, Edlund A (2017) Targeted antimicrobial peptides: a novel technology to eradicate harmful Streptococcus Mutans. J Calif Dent Assoc 45:557–564
pubmed: 29899655 pmcid: 5994769
Tu H, Fan Y, Lv X, Han S, Zhou X, Zhang L (2016) Activity of synthetic antimicrobial peptide GH12 against oral streptococci. Caries Res 50:48–61. https://doi.org/10.1159/000442898
doi: 10.1159/000442898 pubmed: 26859135
Wang Y, Fan Y, Zhou Z, Tu H, Ren Q, Wang X, Ding L, Zhou X, Zhang L (2017) De novo synthetic short antimicrobial peptides against cariogenic bacteria. Arch Oral Biol 80:41–50. https://doi.org/10.1016/j.archoralbio.2017.03.017
doi: 10.1016/j.archoralbio.2017.03.017 pubmed: 28366785
Zhang J, Chen C, Chen J, Zhou S, Zhao Y, Xu M, Xu H (2020) Dual mode of anti-biofilm action of G3 against Streptococcus mutans. ACS Appl Mater Interfaces 12:27866–27875. https://doi.org/10.1021/acsami.0c00771
doi: 10.1021/acsami.0c00771 pubmed: 32484655
Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464–472. https://doi.org/10.1016/j.tibtech.2011.05.001
doi: 10.1016/j.tibtech.2011.05.001 pubmed: 21680034
Silva BRd, Freitas VAAd, Nascimento-Neto LG, Carneiro VA, Arruda FVS, Aguiar ASWd, Cavada BS, Teixeira EH (2012) Antimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literature. Peptides 36:315–321. https://doi.org/10.1016/j.peptides.2012.05.015
doi: 10.1016/j.peptides.2012.05.015 pubmed: 22664320
Huo L, Zhang K, Ling J, Peng Z, Huang X, Liu H, Gu L (2011) Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans. Arch Oral Biol 56:869–876. https://doi.org/10.1016/j.archoralbio.2011.02.004
doi: 10.1016/j.archoralbio.2011.02.004 pubmed: 21382611
Meir O, Zaknoon F, Cogan U, Mor A (2017) A broad-spectrum bactericidal lipopeptide with anti-biofilm properties. Sci Rep 7:2198. https://doi.org/10.1038/s41598-017-02373-0
doi: 10.1038/s41598-017-02373-0 pubmed: 28526864 pmcid: 5438364
Batoni G, Maisetta G, Esin S (2016) Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 1858:1044–1060. https://doi.org/10.1016/j.bbamem.2015.10.013
doi: 10.1016/j.bbamem.2015.10.013 pubmed: 26525663
Robertson J, McGoverin C, Vanholsbeeck F, Swift S (2019) Optimisation of the protocol for the LIVE/DEAD(®) BacLight(TM) bacterial viability kit for rapid determination of bacterial load. Front Microbiol 10:801. https://doi.org/10.3389/fmicb.2019.00801
doi: 10.3389/fmicb.2019.00801 pubmed: 31031741 pmcid: 6474257
Jiang X, Wang Y, Li X, Feng Z, Zeng Y, Han S, Takahashi N, Zhang L (2022) Development and evaluation of a chewing gum containing antimicrobial peptide GH12 for caries prevention. Eur J Oral Sci 130:e12887. https://doi.org/10.1111/eos.12887
doi: 10.1111/eos.12887 pubmed: 35917355
Xiong K, Chen X, Zhu H, Ji M, Zou L (2022) Anticaries activity of GERM CLEAN in Streptococcus mutans and Candida albicans dual-species biofilm. Oral Dis 28:829–839. https://doi.org/10.1111/odi.13799
doi: 10.1111/odi.13799 pubmed: 33583105
Wisdom C, VanOosten SK, Boone KW, Khvostenko D, Arnold PM, Snead ML, Tamerler C (2016) Controlling the biomimetic implant interface: modulating antimicrobial activity by spacer design. J Mol Eng Mater. https://doi.org/10.1142/s2251237316400050
doi: 10.1142/s2251237316400050 pubmed: 28936427 pmcid: 5604879
Röckendorf N, Nehls C, Gutsmann T (2022) Design of membrane active peptides considering multi-objective optimization for biomedical application. Membranes 12:180
doi: 10.3390/membranes12020180 pubmed: 35207101 pmcid: 8880019
Ma Y, Guo Z, Xia B, Zhang Y, Liu X, Yu Y, Tang N, Tong X, Wang M, Ye X, Feng J, Chen Y, Wang J (2022) Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nat Biotechnol 40:921–931. https://doi.org/10.1038/s41587-022-01226-0
doi: 10.1038/s41587-022-01226-0 pubmed: 35241840
Huang DB, Brothers KM, Mandell JB, Taguchi M, Alexander PG, Parker DM, Shinabarger D, Pillar C, Morrissey I, Hawser S, Ghahramani P, Dobbins D, Pachuda N, Montelaro R, Steckbeck JD, Urish KL (2022) Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class. PLoS ONE 17:e0274815. https://doi.org/10.1371/journal.pone.0274815
doi: 10.1371/journal.pone.0274815 pubmed: 36112657 pmcid: 9481017
Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I (2001) Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 31:1066–1075. https://doi.org/10.1002/1521-4141(200104)31:4%3c1066::aid-immu1066%3e3.0.co;2-#
doi: 10.1002/1521-4141(200104)31:4<1066::aid-immu1066>3.0.co;2-# pubmed: 11298331
Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23:291–296. https://doi.org/10.1016/s1471-4906(02)02246-9
doi: 10.1016/s1471-4906(02)02246-9 pubmed: 12072367
Lee J-K, Chang SW, Perinpanayagam H, Lim S-M, Park Y-J, Han SH, Baek S-H, Zhu Q, Bae K-S, Kum K-Y (2013) Antibacterial efficacy of a human β-defensin-3 peptide on multispecies biofilms. Journal of Endodontics 39:1625–1629. https://doi.org/10.1016/j.joen.2013.07.035
doi: 10.1016/j.joen.2013.07.035 pubmed: 24238461
Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63:1291–1297. https://doi.org/10.1128/iai.63.4.1291-1297.1995
doi: 10.1128/iai.63.4.1291-1297.1995 pubmed: 7890387 pmcid: 173149
Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Tanaka S, Heumann D (2002) Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 9:972–982. https://doi.org/10.1128/cdli.9.5.972-982.2002
doi: 10.1128/cdli.9.5.972-982.2002 pubmed: 12204946 pmcid: 120071
Pirtskhalava M, Amstrong AA, Grigolava M, Chubinidze M, Alimbarashvili E, Vishnepolsky B, Gabrielian A, Rosenthal A, Hurt DE, Tartakovsky M (2021) DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res 49:D288–D297. https://doi.org/10.1093/nar/gkaa991
doi: 10.1093/nar/gkaa991 pubmed: 33151284
Shi G, Kang X, Dong F, Liu Y, Zhu N, Hu Y, Xu H, Lao X, Zheng H (2022) DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides. Nucleic Acids Res 50:D488–D496. https://doi.org/10.1093/nar/gkab651
doi: 10.1093/nar/gkab651 pubmed: 34390348
Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L (2017) Isoleucine/leucine residues at “a” and “d” positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide. Amino Acids 49:193–202. https://doi.org/10.1007/s00726-016-2350-9
doi: 10.1007/s00726-016-2350-9 pubmed: 27778166

Auteurs

Xinxin Ying (X)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Guanglu Xue (G)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Pengxiang Sun (P)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Ziling Gan (Z)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Ziqian Fan (Z)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Bo Liu (B)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Yaoting Han (Y)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Jiaqian Yang (J)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China.

Jing Zhang (J)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China. zhangjing@tongji.edu.cn.

Aiping Lu (A)

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200010, China. APLV@tongji.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH